MGNX Stock Ownership Breakdown

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own MGNX shares is 173, representing 93.65% of the company's common stock.

FMR LLC, in the last quarter, reduced its stake in MGNX by -13.3% restricting it's holding to 75.51 thousand shares of worth nearly $1.11M. ALLIANCEBERNSTEIN L.P. also lessened -37.7% of the MGNX shares from its portfolio, reducing its holding to 67.03 thousand shares of worth $986.68K. LOS ANGELES CAPITAL MANAGEMENT LLC also shunned MGNX shares holding by -11.96% last quarter which brought its holding to 53.11 thousand shares worth $781.82K.

As per its latest 13F filing, JACOBS LEVY EQUITY MANAGEMENT, INC increased its stake in MGNX by 28.73% in the last quarter. The institutional holder raised its holding to 148.02 thousand shares having worth more than $2.18M. STATE OF WISCONSIN INVESTMENT BOARD also added 168.28% more shares of MGNX to its portfolio, raising its holding to 78.87 thousand shares of worth $1.16M. AMERICAN CENTURY COMPANIES INC also increased its MGNX shares holding by 23.48% which brought its holding to 63.43 thousand shares worth $933.66K.

The insider with the most stakes in MGNX is BIOTECH TARGET N V , 10 percent owner at the company. Additionally, MGNX stock is highly held by SVP, CFO and Secretary Karrels James and Sr VP, Research & CSO Bonvini Ezio among others.

Company executives, directors, and other insiders own 2.65% percent of MacroGenics, Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which MGNX insiders have sold stock, totaling 0 shares. Insiders that have sold shares include PETERS JEFFREY STUART, RISSER ERIC BLASIUS, and KARRELS JAMES.

There have been 0 transaction(s) during the past 6-months in which MacroGenics, Inc. insiders have bought stock, totalling 0 shares

Around 0 MacroGenics, Inc. shares are held by insiders, which represents about 2.65% of MGNX stock.

MGNX 10 percent owner, BIOTECH TARGET N V holds the largest portfolio of the company's shares. MGNX shares owned by BIOTECH total nearly 9.93 million.

JACOBS LEVY EQUITY MANAGEMENT, INC is the largest institutional owner in MGNX which holds 148.02 thousand shares worth $2.18M or 0% of the total MGNX shares outstanding followed by STATE OF WISCONSIN INVESTMENT BOARD with ownership of 78.87 thousand shares representing 0% of the MGNX ownership. FMR LLC is the third largest stakeholder with 75.51 thousand shares or 0% of the ownership worth more than $1.11M.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the MGNX is concerned, it is a stock which is optionable.

Number of MGNX shares short is 5.28M. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 62.76M shares of MGNX are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, MGNX has 51.74M shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for MGNX is 10.89.